Choices of therapeutic strategies for hepatocellular carcinoma (HCC)
- Conditions
- Liver cell carcinomaC22.0
- Registration Number
- DRKS00025099
- Lead Sponsor
- Chirurgische Klinik, Universitätsmedizin Mannheim
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
All specialists at surgical, internal medicine and radiation therapy departments involved in the treatment of liver cancer patients are eligible to take part in the survey.
Exclusion Criteria
Participants did not completely answer the survey.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the therapy recommendation for the treatment of hepatocellular carcinoma given by the survey participants. This is collected as part of an online questionnaire as soon as the participants have completely answered the survey.
- Secondary Outcome Measures
Name Time Method